Articles By Nushin Rashidian
Cannabis Regulators Respond to Coronavirus Concerns
US cannabis consumers and patients are asking questions like: will my local shop close? Will delivery be an option? Cannabis Wire is tracking cannabis regulators’ announcements.
Coronavirus Delays: Where Do Cannabis Bills Stand Across the US?
Several states were tackling medical or adult use legalization bills before the COVID-19 pandemic hit. Cannabis Wire reached out to key lawmakers to learn the latest.
Analysis: DEA Releases Long-Awaited Rules for Federal Cannabis Research
In 2016, the US Drug Enforcement Administration said it would, for the first time, open applications for those hoping to become federally-licensed cannabis researchers. The details came four years later.
Q&A: Here’s What the CDC Has Learned About Cannabis Workplace Hazards
Cannabis Wire spoke with the CDC’s National Institute for Occupational Safety and Health about the emerging cannabis industry and its workers.
What’s in the US Food and Drug Administration’s CBD Report to Congress?
The FDA is reopening public comment, collaborating with global regulators on how to handle cannabinoids, and backing research on CBD and “dermal penetration.”
Analysis: The World Health Organization Says Cannabis Is Medicine. What Does the US Have to Say?
A global vote this week on the WHO’s position will be delayed. But here’s what the US (and other countries) have said so far.
Global Vote on Cannabis as Medicine Expected to Be Delayed Again
Cannabis Wire reviewed a draft decision to delay until December the UN Commission on Narcotic Drugs vote on the World Health Organization’s recommendation to reschedule cannabis.
Cannabis for Research: The Great Silence
In a Q&A, the founder of one of the companies hoping for a federal license to supply researchers shares the frustrations of the process.
Lawmakers Look to Next Year as New Mexico Cannabis Legalization Push Hits a Wall
Despite vocal support from the governor, a Senate committee has tabled the Cannabis Regulation Act.
